A new era for hepatocellular carcinoma

doi:10.21037/hbsn-23-10

Editorial

. 2023 Feb 28;12(1):135-136.

doi: 10.21037/hbsn-23-10. Epub 2023 Jan 16.

A new era for hepatocellular carcinoma

Riccardo Memeo¹, Antonio Rosario Pisani², Michele Ammendola³, Nicola de'Angelis⁴, Riccardo Inchingolo⁵

Affiliations

¹ Division of Hepato-Pancreato-Biliary Surgery, "F. Miulli" General Hospital, Acquaviva delle Fonti, Bari, Italy.
² Nuclear Medicine Unit, Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro', Bari, Italy.
³ Science of Health Department, Digestive Surgery Unit, University "Magna Graecia" Medical School, Catanzaro, Italy.
⁴ Unit of Colorectal and Digestive Surgery, DIGEST Department, Beaujon University Hospital (AP-HP), University Paris Cité, Clichy, France.
⁵ Interventional Radiology Unit, "F. Miulli" Regional General Hospital, Acquaviva Delle Fonti, Bari, Italy.

PMID: 36860265
PMCID: PMC9944532
DOI: 10.21037/hbsn-23-10

Editorial

A new era for hepatocellular carcinoma

Riccardo Memeo et al. Hepatobiliary Surg Nutr. 2023.

. 2023 Feb 28;12(1):135-136.

doi: 10.21037/hbsn-23-10. Epub 2023 Jan 16.

Authors

Riccardo Memeo¹, Antonio Rosario Pisani², Michele Ammendola³, Nicola de'Angelis⁴, Riccardo Inchingolo⁵

Affiliations

¹ Division of Hepato-Pancreato-Biliary Surgery, "F. Miulli" General Hospital, Acquaviva delle Fonti, Bari, Italy.
² Nuclear Medicine Unit, Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro', Bari, Italy.
³ Science of Health Department, Digestive Surgery Unit, University "Magna Graecia" Medical School, Catanzaro, Italy.
⁴ Unit of Colorectal and Digestive Surgery, DIGEST Department, Beaujon University Hospital (AP-HP), University Paris Cité, Clichy, France.
⁵ Interventional Radiology Unit, "F. Miulli" Regional General Hospital, Acquaviva Delle Fonti, Bari, Italy.

PMID: 36860265
PMCID: PMC9944532
DOI: 10.21037/hbsn-23-10

No abstract available

Keywords: Consensus statement; Hepatocellular carcinoma (HCC); Japan Society of Hepatology; guidelines.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-10/coif). The authors have no conflicts of interest to declare.

Comment on

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.
Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T. Kudo M, et al. Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19. Liver Cancer. 2021. PMID: 34239808 Free PMC article. Review.

Cited by

Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular carcinoma: a Systematic Review and meta-analysis.
Wu D, Liu N, Dong H, Zhou K, Du L, Li Y, Chao Y, Ma F. Wu D, et al. Front Oncol. 2025 May 9;15:1504917. doi: 10.3389/fonc.2025.1504917. eCollection 2025. Front Oncol. 2025. PMID: 40416873 Free PMC article.
Simulating the in vivo tumor microenvironment-advances in building a vascularized model of hepatocellular carcinoma through 3D bioprinting.
Du L, Yang H. Du L, et al. Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):882-884. doi: 10.21037/hbsn-24-154. Epub 2024 Sep 26. Hepatobiliary Surg Nutr. 2024. PMID: 39507735 Free PMC article. No abstract available.
AI-Based Quantification of Enhancing Tumor Volume on Contrast-Enhanced MRI to Predict Pathologic Response and Prognosis in HCC After HAIC Plus Targeted Therapy and Immunotherapy.
Zhou Y, Li J, Li Q, Liu L, Huang P, Mao Y, Yang Y, Lv F, Liu Z. Zhou Y, et al. J Hepatocell Carcinoma. 2025 Jul 21;12:1509-1525. doi: 10.2147/JHC.S527789. eCollection 2025. J Hepatocell Carcinoma. 2025. PMID: 40718076 Free PMC article.

References

1. Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 2022;76:681-93. 10.1016/j.jhep.2021.11.018 - DOI - PMC - PubMed
1. Kudo M, Kawamura Y, Hasegawa K, et al. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer 2021;10:181-223. 10.1159/000514174 - DOI - PMC - PubMed
1. Inchingolo R, Faletti R, Grazioli L, et al. MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients. World J Hepatol 2018;10:462-73. 10.4254/wjh.v10.i7.462 - DOI - PMC - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 2022;76:681-93. 10.1016/j.jhep.2021.11.018 - DOI - PMC - PubMed

[2] Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 2022;76:681-93. 10.1016/j.jhep.2021.11.018 - DOI - PMC - PubMed

[3] Kudo M, Kawamura Y, Hasegawa K, et al. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer 2021;10:181-223. 10.1159/000514174 - DOI - PMC - PubMed

[4] Kudo M, Kawamura Y, Hasegawa K, et al. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer 2021;10:181-223. 10.1159/000514174 - DOI - PMC - PubMed

[5] Inchingolo R, Faletti R, Grazioli L, et al. MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients. World J Hepatol 2018;10:462-73. 10.4254/wjh.v10.i7.462 - DOI - PMC - PubMed

[6] Inchingolo R, Faletti R, Grazioli L, et al. MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients. World J Hepatol 2018;10:462-73. 10.4254/wjh.v10.i7.462 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A new era for hepatocellular carcinoma

Affiliations

A new era for hepatocellular carcinoma

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources